![K. Min](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
K.
Chris Min is a former Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and a former VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min holds an undergraduate degree from Harvard University and doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Precedenti posizioni note di K. Min
Società | Posizione | Fine |
---|---|---|
LONGEVERON INC. | Amministratore Delegato | 01/03/2023 |
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | 01/04/2021 |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Formazione di K. Min
Weill Cornell Medical College | Doctorate Degree |
The Rockefeller University | Doctorate Degree |
Harvard University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Aziende private | 2 |
---|---|
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Bluerock Therapeutics, Inc. |
- Borsa valori
- Insiders
- K. Min